The limited effect of PD-1 blockade on this background may be explained partly by the result that a major source of PD-L1 in the TME is MDSC, which has been inhibited by GEM, and the possibility that other mechanisms of resistance to tumor immunity may play a role in the current model system. Here, PDCD1 is linked to neoplasm.